Veeva Systems announced that CARMAT selected Veeva Vault eTMF to simplify trial master file management. By streamlining clinical trial documentation, Vault eTMF will drive efficiency and enable CARMAT with better visibility across its global studies. CARMAT, the designer and developer of the world's first total bioprosthetic artificial heart, managed study documents manually, resulting in suboptimal visibility and lengthy TMF reviews. Vault eTMF will enable CARMAT to actively manage all TMF processes and documents on a single cloud platform for transparency into the appropriateness of documentation. This will help CARMAT's teams to focus on patients and innovation that can save lives. Vault eTMF is part of Veeva Vault Clinical Operations Suite, enabling companies to seamlessly share information and documents across CTMS, eTMF, study start-up, and payments for better collaboration and increased efficiency throughout the study lifecycle.